Hypertension as a persistent public health problem. A position paper from Alliance for a Healthy Heart, Mexico
Main Article Content
Abstract
Today, Mexico has more than 130 million inhabitants; 85 millions of them are adults of 20 or more years old. The population pyramid is still one of base wider and this base corresponds to adults younger than 54 years old. Despite predictions made 20 years ago, about a transformation of the population pyramid shape to a mushroom shape as a consequence of more life expected and adult population growth; this change has not been occurred. Hypertension has become the biggest challenge of noncommunicable chronic diseases to public health in Mexico. Around 30% of adult Mexican population has hypertension; 75% of them have less than 54 years old (in productive age); 40% of them are unaware but only 50% of aware hypertensive population takes drugs and, 50% of them are controlled (< 140/90 mmHg). Cardiovascular risk factors including hypertension, dyslipidemia, obesity, and diabetes often cohabit in the same person and are magnified one to another in terms of common pathophysiological pathways. Atherosclerosis, arrhythmias, stroke and heart failure are common and are the final pathologic end-points and explains why cardiovascular diseases occupy first place in mortality in Mexico and worldwide. The costs of care for these diseases are billionaires and if we do not generate appropriate strategies, their global impact can become a high threat to social development of the country. The life style like nutrition, sports habits of the Mexicans must be emphasized; there is poor education about this crucial topic. This position paper is focused on the principal controversies and strategies to be developed by all, government, society, physicians, nurses, patients and all people related with healthcare of hypertension, in order to confront this huge public health problem in Mexico.
Article Details
Copyright (c) 2019 Alcocer L, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Proyecto de Norma Oficial Mexicana. PROY-NOM-030-SSA2-2017 Para la prevención, detección, diagnóstico, tratamiento y control de la hipertensión arterial sistémica. Diario Oficial de la Federación. Ref.: https://goo.gl/oLUJwp
Williams B, Mancia G, Spiering W, Agabiti ER, Azizi M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J, 2018; 39: 3021-3104. Ref.: https://goo.gl/KP2aAC
Whelton PK, Carey RM, Aronow WS, Casey Jr DE, Collins KJ, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology. Hypertension. 2018; 71: 1269-1324. Ref.: https://goo.gl/1xpEDP
Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, et al. A Controlled Trial of Renal Denervation for Resistant Hypertension. N Engl J Med. 2014; 370: 1393-1401. Ref.: https://goo.gl/GH7125
Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, et al. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension. 2015; 65: 766-774. Ref.: https://goo.gl/i5B6iX
Sheppard JP, Schwartz CL. Modern Management and Diagnosis of Hypertension in the United Kingdom: Home Care and Self-care. Annals of Global Health. 2016; 82: 274-287. Ref.: https://goo.gl/EKjbBx
Task Force of the Latin American Society of Hypertension. Guidelines on the management of arterial hypertension and related comorbidities in Latin America. J Hypertens. 2017: 35: 1529–1545. Ref.: https://goo.gl/LySHJV
Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, et al. Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2018; 34: 506-525. Ref.: https://goo.gl/Mq8MRJ
Velázquez MO, Rosas PM, Lara EA, Pastelín HG, Grupo ENSA 2000. Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000 Arch Cardiol Mex 2002; 72: 71-84. Ref.: https://goo.gl/g7BmFW
Barquera S, Campos-Nonato I, Hernández-Barrera L, Villalpando S, Rodríguez-Gilabert C, et al. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex. 2010; 52 (S1): S63-S71. Ref.: https://goo.gl/nmNVQ5
Rosas Peralta M, Palomo Piñón S, Borrayo Sánchez, Madrid Miller A, Almeida Gutiérrez E, et al. Consenso de hipertensión arterial sistémica en México. Rev Med Inst Seguro Soc 2016;54:S6-S51 Ref.: https://goo.gl/eTVyKu
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: Un update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28: 1-39. Ref.: https://goo.gl/cmSMkG
Rosas-Peralta M, Borrayo-Sánchez G, Madrid-Miller A, Ramírez-Arias E, Pérez-Rodríguez G. Hipertensión durante el embarazo: el reto continúa. Rev Med Inst Mex Seg Soc. 2016; 54 Supl 1: s90-111. Ref.: https://goo.gl/mC4k5y
Upadhyay A, Earley A, Haynes SM, Uhlig K Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med. 2011;154: 541-548. Ref.: https://goo.gl/Drd3NW
Peralta MR, Sánchez GB, Arias ER, Genchi GMJ, González MAH, et al. Cardiovascular risk reduction: Past, present and future in Mexico. Ann Clin Hypertens. 2018; 2: 38-47. Ref.: https://goo.gl/LP3e63
Michael LeFevre, ACC/AHA Hypertension Guideline: What Is New? What Do We Do? 2018; 97: 6. Ref.: https://goo.gl/HzoxzB
World Health Organization. A global brief on hypertension. Silent killer, global public health crisis. Ginebra: WHO, 2013. Ref.: https://goo.gl/nTrtLS
Campos-Nonato I, Hernandez-Barrera L, Rojas-Martinez R, Pedroza A, Medina-Garcia C, et al. Hypertension: prevalence, early diagnosis, control and trends in Mexican adults. Salud Publica Mex. 2013; 55 (supl 2): S144-50. Ref.: https://goo.gl/mr8uLZ
Rosas-Peralta M, Borrayo-Sánchez G, Santiago-López J, Árias ER, Méndez RG, et al. What is new in Hypertension of Mexico 2018? Impact of the new classification of high blood pressure. Ann Clin Hypertens. 2018; 2:24-30. Ref.: https://goo.gl/CaC6rs
Secretaría de Salud, Dirección General de Epidemiología. Anuario de Morbilidad 1984-2016. Incidencia. Casos nuevos de enfermedad por grupo de edad. México: Secretaría de Salud, 2018 [citado abril 23, 2017]. Disponible en: Ref.: https://goo.gl/idYreE
Registros administrativos [internet]. Mortalidad. Conjunto de datos: Mortalidad general (1990-2016). Tabulación para mortalidad de la CIE [citado abril 23, 2017]. Aguascalientes: Instituto Nacional de Estadística y Geografía, 2017. Disponible en: Ref.: https://goo.gl/pr8hHq
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388:1659-724. Ref.: https://goo.gl/t5zgqi
Meaney E, Alva F, Moguel R, Meaney A, Alva J, et al. Formula and nomogram for the sphygmomanometric calculation of the mean arterial pressure. Heart. 2000; 84: 64. Ref.: https://goo.gl/Reqzmw
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005; 45: 142-161. Ref.: https://goo.gl/hYMXUE
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311: 507-520. Ref.: https://goo.gl/tUzzk8